Bristol-Myers Squibb Co BMY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 07/01/24 EDT

41.34

+0.04 (+0.10%)

Volume

3,890,997

41.30UNCH (UNCH)

Volume

10,870,833

52 week range

39.63 - 65.38

Open41.65
Day High42.27
Day Low41.13
Prev Close41.30
52 Week High65.38
52 Week High Date07/24/23
52 Week Low39.63
52 Week Low Date06/20/24

Key Stats

Market Cap83.719B
Shares Out2.03B
10 Day Average Volume19.50M
Dividend2.40
Dividend Yield5.81%
Beta0.44
YTD % Change-19.51

KEY STATS

Open41.65
Day High42.27
Day Low41.13
Prev Close41.30
52 Week High65.38
52 Week High Date07/24/23
52 Week Low39.63
52 Week Low Date06/20/24
Market Cap83.719B
Shares Out2.03B
10 Day Average Volume19.50M
Dividend2.40
Dividend Yield5.81%
Beta0.44
YTD % Change-19.51

RATIOS/PROFITABILITY

EPS (TTM)-3.10
P/E (TTM)-13.31
Fwd P/E (NTM)6.03
EBITDA (TTM)20.37B
ROE (TTM)-25.45%
Revenue (TTM)45.534B
Gross Margin (TTM)75.94%
Net Margin (TTM)-13.47%
Debt To Equity (MRQ)337.64%

EVENTS

Earnings Date07/26/2024(est)
Ex Div Date07/05/2024
Div Amount0.60
Split Date-
Split Factor-

Latest On Bristol-Myers Squibb Co

Pfizer struggles to regain faith with Wall Street, employees after Covid declineJune 28, 2024CNBC.com
Biden to lower costs for 64 drugs through inflation penalties on drugmakersJune 26, 2024CNBC.com
Lightning Round: Look to buy more Cava if it comes down, says Jim CramerJune 24, 2024CNBC.com
Cramer's Lightning Round: 'I would not abandon' CavaJune 24, 2024CNBC.com
Healthy Returns: AstraZeneca, other drugmakers release promising cancer dataJune 7, 2024CNBC.com

Content From Our Affiliates

Ex-Dividend Date Nearing for These 10 Stocks – Week of July 1, 2024June 30, 2024TipRanks
2seventy Bio announces sale of Hemophilia A candidate for up to $40MJune 26, 2024TipRanks
Bristol Myers Squibb call volume above normal and directionally bullishJune 24, 2024TipRanks
Bristol Myers announces FDA accelerated approval of Krazati for CRCJune 23, 2024TipRanks
FDA approves Mirati’s Krazati sNDA for colorectal cancerJune 21, 2024TipRanks

Profile

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric...

Christopher Boerner Ph.D.

Chairman of the Board, Chief Executive Officer, Chief Operating Officer

David Elkins

Executive Vice President, Chief Financial Officer, Member of the Leadership Team

Cari Gallman

Executive Vice President, Corporate Affairs, Member of the Leadership Team

Sandra Leung

Executive Vice President, General Counsel, Member of the Leadership Team

Adam Lenkowsky

Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team

Address

Route 206 And Province Line Road

Princeton, NJ

08543

United States

https://www.bms.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
GSK GSK plc	38.38	UNCH	UNCH
SNY Sanofi SA	49.59	UNCH	UNCH
GILD Gilead Sciences Inc	68.64	UNCH	UNCH
BAYRY Bayer AG	6.97	-0.07	-0.99%
PFE Pfizer Inc	28.22	UNCH	UNCH